Professor Gerald Holtmann
Professor

Gerald Holtmann

Email: 

Background

Prof Holtmann is a Clinical Academic in the field of Gastroenterology & Hepatology and Director of Clinical Innovation. He is also Director of the Department of Gastroenterology & Hepatology at the Princess Alexandra Hospital in Queensland and serves on the Board of Directors of the West Moreton Hospital and Health Service and UQ Healthcare. He is a Fellow of Royal Australian Collge of Physicians (RACP, Sydney), the Royal College of Physicians (RCP, London) and Fellow of the Australian Academy of Health and Medical Sciences (AAHMS, Canberra). Besides his Medical Qualifications he also obtained a Master of Business Administration. After completing the clinical training in Medicine and Gastroenterology at the University of Essen in Germany and the Mayo Clinic in Rochester, Minnesota in the United States, he has gained substantial leadership and managerial experience within the health care setting as Director of large Gastroenterology Departments, CEO and General Manager of a University Hospital and Health Care Facilities and has served on the Board of the University Hospital Essen in Germany. His research is in the field of Neurogastroenterology has resulted in peer reviewed publications in key journal including the NEJM, Lancet, Gastroenterology and Gut. More recently his rersearch focus is on the role of the gut microbiome, mucosal and systemic inflammation and brain-gut interactions.

Availability

Professor Gerald Holtmann is:
Available for supervision
Media expert

Search Professor Gerald Holtmann’s works on UQ eSpace

663 works between 1937 and 2026
All (663) Journal Article (464) Conference Publication (195) Book Chapter (4)

421 - 440 of 663 works

2010

Conference Publication

Psychogastroenterology: A Biopsychosocial Approach to Treating Inflammatory Bowel Disease (IBD)

Mikocka-Walus, Antonina A., Van Langenberg, Daniel R., Holtmann, Gerald and Andrews, Jane M. (2010). Psychogastroenterology: A Biopsychosocial Approach to Treating Inflammatory Bowel Disease (IBD). PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC.

Psychogastroenterology: A Biopsychosocial Approach to Treating Inflammatory Bowel Disease (IBD)

2010

Conference Publication

A Double-Blind, Randomized, Cross-Over Study on the Effects of STW5 on Symptoms and Immunologic Function in Patients With Irritable Bowel Syndrome

Pilichiewicz, Amelia N., Holtmann, Gerald, Persson, Jenny, Gapasin, Judith, Holloway, Richard H., Goess, Charlotte, Zschau, Nora B., Lefebvre, Eve, Faraguna, Lee-Anne, Adam, Birgit, Liebregts, Tobias and Andrews, Jane M. (2010). A Double-Blind, Randomized, Cross-Over Study on the Effects of STW5 on Symptoms and Immunologic Function in Patients With Irritable Bowel Syndrome. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC.

A Double-Blind, Randomized, Cross-Over Study on the Effects of STW5 on Symptoms and Immunologic Function in Patients With Irritable Bowel Syndrome

2010

Conference Publication

Does Cognitive-Behavioural Therapy (CBT) Improve Outcomes in Inflammatory Bowel Disease (IBD)? Initial Feasibility Report on a Pilot Randomised Controlled Trial

Mikocka-Walus, Antonina A., Bond, Melissa, Holloway, Richard H., Persson, Jenny, Pilichiewicz, Amelia N., Hughes, Patrick A., Burke, Anne, Collins, Kathryn, Blackshaw, Ashley, Holtmann, Gerald and Andrews, Jane M. (2010). Does Cognitive-Behavioural Therapy (CBT) Improve Outcomes in Inflammatory Bowel Disease (IBD)? Initial Feasibility Report on a Pilot Randomised Controlled Trial. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC.

Does Cognitive-Behavioural Therapy (CBT) Improve Outcomes in Inflammatory Bowel Disease (IBD)? Initial Feasibility Report on a Pilot Randomised Controlled Trial

2010

Conference Publication

Symptomatic Uncomplicated Peptic Ulcer Disease: True Peptic Ulcer or Functional Dyspepsia?

Gururatsakul, Montri, Andrews, Jane M., Holtmann, Gerald, Talley, Nick and Holloway, Richard H. (2010). Symptomatic Uncomplicated Peptic Ulcer Disease: True Peptic Ulcer or Functional Dyspepsia?. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC.

Symptomatic Uncomplicated Peptic Ulcer Disease: True Peptic Ulcer or Functional Dyspepsia?

2010

Conference Publication

Anxiety Exaggerates the Immune Response to Bacterial Antigen Exposure in Patients With Functional Gastrointestinal Disorders

Adam, Birgit, Liebregts, Tobias, Gururatsakul, Montri, Talley, Nick, Gerken, Guido and Holtmann, Gerald (2010). Anxiety Exaggerates the Immune Response to Bacterial Antigen Exposure in Patients With Functional Gastrointestinal Disorders. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC.

Anxiety Exaggerates the Immune Response to Bacterial Antigen Exposure in Patients With Functional Gastrointestinal Disorders

2010

Conference Publication

STW5 Leads to Changes in Immunologic Response, as Assessed by Cytokine Secretion, in Healthy Controls, but Not Subjects With Irritable Bowel Syndrome (IBS)

Persson, Jenny, Holtmann, Gerald, Pilichiewicz, Amelia N., Gururatsakul, Montri, Yan, Ming-Xian, Khoo, Edmund C., Gapasin, Judith, Goess, Charlotte, Zschau, Nora B., Faraguna, Lee-Anne, Adam, Birgit, Liebregts, Tobias, Holloway, Richard H. and Andrews, Jane M. (2010). STW5 Leads to Changes in Immunologic Response, as Assessed by Cytokine Secretion, in Healthy Controls, but Not Subjects With Irritable Bowel Syndrome (IBS). PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC.

STW5 Leads to Changes in Immunologic Response, as Assessed by Cytokine Secretion, in Healthy Controls, but Not Subjects With Irritable Bowel Syndrome (IBS)

2010

Journal Article

Onset of relief of symptoms of gastroesophageal reflux disease: Post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily

Haag, Sebastian and Holtmann, Gerald (2010). Onset of relief of symptoms of gastroesophageal reflux disease: Post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily. Clinical Therapeutics, 32 (4), 678-690. doi: 10.1016/j.clinthera.2010.03.020

Onset of relief of symptoms of gastroesophageal reflux disease: Post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily

2010

Journal Article

Is there any association between disturbed gastrointestinal visceromotor and sensory function and impaired quality of life in functional dyspepsia?

Haag, S., Senf, W., Tagay, S., Heuft, G., Gerken, G., Talley, N. J. and Holtmann, G. (2010). Is there any association between disturbed gastrointestinal visceromotor and sensory function and impaired quality of life in functional dyspepsia?. Neurogastroenterology and Motility, 22 (3). doi: 10.1111/j.1365-2982.2009.01415.x

Is there any association between disturbed gastrointestinal visceromotor and sensory function and impaired quality of life in functional dyspepsia?

2010

Journal Article

Un-promoted issues in inflammatory bowel disease: Opportunities to optimize care

Andrews, J. M., Mountifield, R. E., Van Langenberg, D. R., Bampton, P. A. and Holtmann, G. J. (2010). Un-promoted issues in inflammatory bowel disease: Opportunities to optimize care. Internal Medicine Journal, 40 (3), 173-182. doi: 10.1111/j.1445-5994.2009.02110.x

Un-promoted issues in inflammatory bowel disease: Opportunities to optimize care

2010

Journal Article

The ageing gut: Diminished symptom response to a standardized nutrient stimulus

Gururatsakul, M., Holloway, R. H., Adam, B., Liebregts, T., Talley, N. J. and Holtmann, G. J. (2010). The ageing gut: Diminished symptom response to a standardized nutrient stimulus. Neurogastroenterology and Motility, 22 (3). doi: 10.1111/j.1365-2982.2009.01413.x

The ageing gut: Diminished symptom response to a standardized nutrient stimulus

2010

Journal Article

Association between clinical manifestations of complicated and uncomplicated peptic ulcer and visceral sensory dysfunction

Gururatsakul, Montri, Holloway, Richard H, Talley, Nicholas J and Holtmann, Gerald J (2010). Association between clinical manifestations of complicated and uncomplicated peptic ulcer and visceral sensory dysfunction. Journal of Gastroenterology and Hepatology (Australia), 25 (6), 1162-1169. doi: 10.1111/j.1440-1746.2010.06269.x

Association between clinical manifestations of complicated and uncomplicated peptic ulcer and visceral sensory dysfunction

2010

Journal Article

Adverse clinical phenotype in inflammatory bowel disease: A cross sectional study identifying factors potentially amenable to change

Van Langenberg, Daniel R., Lange, Kylie, Hetzel, David J., Holtmann, Gerald J. and Andrews, Jane M. (2010). Adverse clinical phenotype in inflammatory bowel disease: A cross sectional study identifying factors potentially amenable to change. Journal of Gastroenterology and Hepatology (Australia), 25 (7), 1250-1258. doi: 10.1111/j.1440-1746.2010.06302.x

Adverse clinical phenotype in inflammatory bowel disease: A cross sectional study identifying factors potentially amenable to change

2009

Journal Article

Management of reflux symptoms with over-the-counter proton pump inhibitors: Issues and proposed guidelines

Haag, Sebastian, Andrews, Jane M., Katelaris, Peter H., Gapasin, Judith, Galmiche, Jean Paul, Hunt, Richard, Layer, Peter, Malfertheiner, Peter and Holtmann, Gerald (2009). Management of reflux symptoms with over-the-counter proton pump inhibitors: Issues and proposed guidelines. Digestion, 80 (4), 226-234. doi: 10.1159/000235953

Management of reflux symptoms with over-the-counter proton pump inhibitors: Issues and proposed guidelines

2009

Journal Article

Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group

Modlin, I. M., Hunt, R. H., Malfertheiner, P., Moayyedi, P., Quigley, E. M., Tytgat, G. N. J., Tack, J., Heading, R. C., Holtman, G., Moss, S. F. and Vevey NERD Consensus Group (2009). Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group. Digestion, 80 (2), 74-88. doi: 10.1159/000219365

Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group

2009

Journal Article

Serotoninergic and non-serotoninergic effects of two tricyclic antidepressants on visceral nociception in a rat model

Bechmann, Lars P., Best, Jan, Haag, Sebastian, Leineweber, Kirsten, Gerken, Guido and Holtmann, Gerald (2009). Serotoninergic and non-serotoninergic effects of two tricyclic antidepressants on visceral nociception in a rat model. Scandinavian Journal of Gastroenterology, 44 (6), 680-686. doi: 10.1080/00365520902767272

Serotoninergic and non-serotoninergic effects of two tricyclic antidepressants on visceral nociception in a rat model

2009

Journal Article

Clinical trial: The treatment of gastro-oesophageal reflux disease in primary care - Prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg

Eggleston, A., Katelaris, P. H., Nandurkar, S., Thorpe, P. and Holtmann, G. (2009). Clinical trial: The treatment of gastro-oesophageal reflux disease in primary care - Prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg. Alimentary Pharmacology and Therapeutics, 29 (9), 967-978. doi: 10.1111/j.1365-2036.2009.03948.x

Clinical trial: The treatment of gastro-oesophageal reflux disease in primary care - Prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg

2009

Journal Article

Does doctors' knowledge of inflammatory bowel disease patients' psychological status affect patients' clinical outcomes: A pilot randomized controlled trial

Mikocka-Walus, Antonina A., Turnbull, Deborah A., Andrews, Jane M., Moulding, Nicole T., Wilson, Ian G. and Holtmann, Gerald (2009). Does doctors' knowledge of inflammatory bowel disease patients' psychological status affect patients' clinical outcomes: A pilot randomized controlled trial. European Journal of Gastroenterology and Hepatology, 21 (4), 484-485. doi: 10.1097/MEG.0b013e32831dac8a

Does doctors' knowledge of inflammatory bowel disease patients' psychological status affect patients' clinical outcomes: A pilot randomized controlled trial

2009

Journal Article

Guideline adherence and patient satisfaction in the treatment of inflammatory bowel disorders - An evaluation study

Pieper, Claudia, Haag, Sebastian, Gesenhues, Stefan, Holtmann, Gerald, Gerken, Guido and Jöckel, Karl-Heinz (2009). Guideline adherence and patient satisfaction in the treatment of inflammatory bowel disorders - An evaluation study. BMC Health Services Research, 9 (1) 17. doi: 10.1186/1472-6963-9-17

Guideline adherence and patient satisfaction in the treatment of inflammatory bowel disorders - An evaluation study

2009

Journal Article

TRPV1-expressing sensory fibres and IBS: Links with immune function

Hughes, P. A., Brierley, S. M., Martin, C. M., Liebregts, T., Persson, J., Adam, B., Holtmann, G. and Blackshaw, L. A. (2009). TRPV1-expressing sensory fibres and IBS: Links with immune function. Gut, 58 (3), 465-466. doi: 10.1136/gut.2008.161760

TRPV1-expressing sensory fibres and IBS: Links with immune function

2009

Journal Article

Relationship Between Symptoms and Dietary Patterns in Patients With Functional Dyspepsia

Pilichiewicz, Amelia N., Horowitz, Michael, Holtmann, Gerald J., Talley, Nicholas J. and Feinle-Bisset, Christine (2009). Relationship Between Symptoms and Dietary Patterns in Patients With Functional Dyspepsia. Clinical Gastroenterology and Hepatology, 7 (3), 317-322. doi: 10.1016/j.cgh.2008.09.007

Relationship Between Symptoms and Dietary Patterns in Patients With Functional Dyspepsia

Current funding

  • 2022 - 2026
    ARC Training Centre for Behavioural Insights for Technology Adoption (BITA) (ARC Industrial Transformation Training Centre Administered by QUT)
    Queensland University of Technology
    Open grant

Past funding

  • 2021 - 2025
    A practice change for patients with severe chronic, clinically unexplained gastrointestinal symptoms: A randomised, controlled intervention to assess efficacy and cost-effectiveness
    NHMRC IDEAS Grants
    Open grant
  • 2020 - 2024
    Modulation of the Gastrointestinal Microbiome with probiotics and subsequent Methane production as a novel approach to treat constipation: A Proof of Principle Study (TRI Sport Grant led by PAH)
    Metro South Hospital and Health Service
    Open grant
  • 2020 - 2025
    Targeting the gut microbiome as a treatment for Primary Sclerosing Cholangitis: The Queensland Clinical Network Study
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2019 - 2024
    Centre for Research Excellence in Digestive Health (NHMRC CRE administered by University of Newcastle)
    University of Newcastle
    Open grant
  • 2016
    Establishing a gnotobiotic germ-free mouse facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    The Australian human microbiota project-microbe isolation facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015 - 2018
    Pathophysiology of functional dyspepsia: Integration of upper gut function, inflammation and a systems biology approach.
    NHMRC Project Grant
    Open grant
  • 2014 - 2017
    Functional dyspepsia: Characterisation of the immunopathology and testing a novel therapeutic strategy (NHMRC Project Grant administered by the University of Newcastle)
    University of Newcastle
    Open grant

Availability

Professor Gerald Holtmann is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Effects the COVID-19 pandemic on the outcome and management of highly prevalent gastrointestinal conditions

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    IBD and mental health tools: a holistic approach to discovery and appropriate tool.

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    Investigating the Role of Exercise in Managing Disorders of the Gut Brain Interaction

    Associate Advisor

    Other advisors: Professor Jeff Coombes

  • Doctor Philosophy

    Targeting the gastrointestinal mucosa associated microbiome to improve clinical outcomes

    Associate Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    Study of TOfacitinib for the treatment of chronic Pouchitis

    Associate Advisor

    Other advisors: Associate Professor Jakob Begun

  • Doctor Philosophy

    The role of the gut microbiome in alcohol related liver disease

    Associate Advisor

    Other advisors: Professor Jason Connor, Honorary Professor Paul Clark

Completed supervision

Enquiries

Contact Professor Gerald Holtmann directly for media enquiries about:

  • colon cancer screening
  • Gastroenterology
  • Gut Health
  • Microbiome
  • Neurogastroenterology

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au